Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Infinity Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (160)	1/9/2008 8:49:47 PM
From: tuck	Respond to of 210

Hi, Mike! Hope the holidays treated you and yours well. I traded INFI a while back for a modest gain on technicals -- playing a bounce off of the last dip; I believe I made a buck and a half per share. I continue to watch. It is well funded, which is crucial these days. But real share price driving news doesn't come until the next half of the year. Though, this half, if they delay starting their various trials, that would be negative. I believe these considerations explain the weakness; market sees dead money or slightly worse. However, I don't think there is much more downside, and a few months patience should be rewarded with an anticipatory run into release of results. As such, I might nibble here, but I expect further market weakness, which may take INFI a bit further down the rabbit hole. So I wouldn't look for a whole position until late early summer. Cheers, Tuck